Obesity, Metabolic Abnormality, and Progression of CKD

Medicine and Dentistry

• Obesity 100%
• Chronic Kidney Disease 90%
• Disease Exacerbation 45%
• Patient 27%
• Study Design 27%
• Cohort Analysis 18%
• Association 18%
• Body Mass Index 9%
• Cardiovascular Disease 9%
• High Density Lipoprotein Cholesterol 9%
• Triacylglycerol 9%
• Predictor 9%
• Glucose 9%
• Maturity Onset Diabetes of the Young 9%
• C Reactive Protein 9%
• Hypertension 9%
• Follow up 9%
• Deterioration 9%
• Glomerular Filtration Rate 9%
• Hypolipidemic Agent 9%
• End Stage Renal Disease 9%
• Man 9%
• Inpatient 9%
• Woman 9%
• Adjustment 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Obesity 100%
• Chronic Kidney Failure 90%
• Disease Exacerbation 45%
• Observational Study 27%
• Hypertension 9%
• Non Insulin Dependent Diabetes Mellitus 9%
• Glucose 9%
• Triacylglycerol 9%
• C Reactive Protein 9%
• High Density Lipoprotein Cholesterol 9%
• Antilipemic Agent 9%
• Confounder 9%
• End Stage Renal Disease 9%

Biochemistry, Genetics and Molecular Biology

• Association 18%
• Cohort Study 18%
• Triacylglycerol Level 9%
• High Density Lipoprotein Cholesterol Level 9%
• Body Mass 9%
• C-Reactive Protein 9%
• Glucose Level 9%
• Glomerulus Filtration 9%
• Adjustment 9%
• Lipid 9%